Location: | London |
---|---|
Salary: | £43,124 to £46,546 |
Hours: | Full Time |
Contract Type: | Fixed-Term/Contract |
Placed On: | 23rd October 2024 |
---|---|
Closes: | 13th November 2024 |
Job Ref: | B02-07830 |
About us
The EGA Institute for Women’s Health is an exciting and dynamic environment and its mission is to bring together the expertise of clinicians and researchers from a diverse range of disciplines so that they can deliver excellence and innovation in research, clinical practice, education and training in order to make a real and sustainable difference to women's and babies’ health locally, nationally and worldwide.
About the role
The role is to develop a pre-clinical gene therapy treatment for rare epilepsy, and the duties and responsibilities involve evaluating efficacy of viral-gene therapies in a transgenic mouse model of neurological disease through stereotactic administration of treatment, behavioural assessment and tissues analysis.
The candidate will engage on a programme of post-doctoral research full-time, until 28/02/2029.
The candidate will be expected to undertake teaching at undergraduate/postgraduate levels and carry out other forms of public presentation. Applicants should have a higher academic degree e.g. PhD and evidence of an equivalent level of attainment in research publications.
This role meets the eligibility requirements for a skilled worker certificate of sponsorship or a global talent visa under UK Visas and Immigration legislation. Therefore, UCL welcomes applications from international applicants who require a visa.
This appointmen t is subject to UCL Terms and Conditions of Service for Research and Professional Services Staff. Please visit https://www.ucl.ac.uk/human-resources/conditions-service-research-teaching-and-professional-services-staff for more information.
About you
We are looking for an individual who has extensive experience in neuroscience and gene therapy.
Experience in-vivo work (Home office personal licence for animal research), performing stereotactic injections and electroencephalogram (EEG) implant surgery/recording for seizures. Previous experience with in-vivo behavioural work, tissue analysis (qPCR, western blot and immunohistochemistry) and gene therapy vector production are essential.
Excellent interpersonal skills and flexible attitude to shift work are essential as well as the ability to work unsupervised on occasion. Applicants should hold a PhD in neuroscience and gene therapy. For the right candidate there will be an opportunity to gain new skills in translational gene therapy project, writing project reports for funder, research paper writing, grant writing/submission.
Appointment at Grade 7 is dependent upon having been awarded a PhD; if this is not the case, initial appointment will be at Grade 6B spine point with payment at Grade 7 being backdated to the date of final submission of the PhD Thesis.
What we offer
As well as the exciting opportunities this role presents, we also offer great benefits.
Please visit https://www.ucl.ac.uk/work-at-ucl/rewards-and-benefits to find out more.
Early application submission is recommended.
The salary range for this role is UCL Grade 7: £43,124- £ 46,546 per annum inclusive of London Allowance.
Our commitment to Equality, Diversity and Inclusion
As London’s Global University, we know diversity fosters creativity and innovation, and we want our community to represent the diversity of the world’s talent. We are committed to equality of opportunity, to being fair and inclusive, and to being a place where we all belong.
We therefore particularly encourage applications from candidates who are likely to be underrepresented in UCL’s workforce.
These include people from Black, Asian and ethnic minority backgrounds; disabled people; LGBTQI+ people; and for our Grade 9 and 10 roles, women. You can read more about our commitment to Equality, Diversity and Inclusion here : https://www.ucl.ac.uk/equality-diversity-inclusion/
Type / Role:
Subject Area(s):
Location(s):